• Info
  • Insider Ownership

Insider Trading & Ownership of JAMES HEALY

Location
Menlo Park, CA
Summary
The estimated net worth of JAMES HEALY is at least $293M dollars as of 18 Sep 2025. JAMES HEALY is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $226M. JAMES HEALY is the Director of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $41.5M. JAMES HEALY is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $19.9M. JAMES HEALY is the Director of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $6.19M.
Signature
/s/ John LaRocca, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when JAMES HEALY files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of JAMES HEALY

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $226M 25 Apr 2025
BIOA BioAge Labs, Inc. Director $41.5M 05 Jun 2025
RAPP Rapport Therapeutics, Inc. Director $19.9M 17 Jun 2025
AVBP ArriVent BioPharma, Inc. Director $6.19M 30 Jan 2024
KRTX Karuna Therapeutics, Inc. Director $0 18 Mar 2024
YMAB Y-mAbs Therapeutics, Inc. Director $0 16 Sep 2025
BOLT Bolt Biotherapeutics, Inc. Director 12 Jun 2024
CINC CinCor Pharma, Inc. Director, 10%+ Owner 28 Nov 2022
CHRS Coherus BioSciences, Inc. Director 07 Jan 2022

Insider Transactions Reported by JAMES HEALY:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.